Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Wegovy pre-filled pen contains 1.5 ml of solution, and that volume stays the same across every strength in the range. The dose (the amount of semaglutide your prescriber has set) changes with each new pen; the liquid volume does not. Understanding this distinction matters, because it is the most common source of confusion readers bring to this question. Wegovy is a prescription-only medicine requiring clinical assessment before a prescriber determines which strength is right for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Many people assume that as Wegovy doses increase (from 0.25 mg right through to 2.4 mg, or the newer 7.2 mg strength approved by the MHRA in April 2026) each pen must contain more liquid. It does not. The 1.5 ml fill is fixed. What changes is the concentration of semaglutide dissolved in that liquid. A 2.4 mg pen and a 0.25 mg pen look almost identical in your hand; the difference is invisible to the eye.
This is how most pre-filled injection pens for medicines like semaglutide work. The manufacturer fixes the physical size of the cartridge, then adjusts how much active ingredient sits in each millilitre. So when you move to a higher strength, you are not injecting more fluid, you are injecting the same 1.5 ml at a higher concentration. Our detailed breakdown of Wegovy pen volume walks through exactly how concentrations differ across the full range if you want to compare strengths side by side.
The practical takeaway: never try to judge your dose by looking at the syringe barrel. The only reliable check is the strength printed on the label.
Before you inject, spend thirty seconds on this: read the strength printed on the outer carton, then read it again on the pen itself. They should match. If they do not (or if the labelling is missing, unclear, or shows a brand you were not expecting) stop and contact your pharmacy or prescriber before proceeding.
This habit takes less than a minute and it matters more than most people realise. Counterfeit and unlicensed weight-loss pens do circulate in the UK, and the MHRA has warned publicly that fake pens have occasionally contained entirely different substances. Verifying the label is the first line of defence. If you have any doubt about a pen you have received, you can report a suspect product through the MHRA's Yellow Card scheme, the same reporting tool used for suspected side effects.
It is also worth knowing that the pen is a single-use device delivering one weekly injection. There is no mechanism to adjust the amount it releases mid-injection. How many injections you get from a Wegovy pen covers the per-pen and per-month picture in more detail.
The MHRA approved a dedicated single-dose 7.2 mg Wegovy pen on 14 April 2026, the highest strength available and the newest addition to the range. As with all other strengths, the physical volume of solution in this pen follows the same 1.5 ml standard. The higher dose is achieved through higher concentration, not a larger cartridge.
The 7.2 mg pen is licensed for adults with a BMI of 30 or above. It is the maximum dose in the Wegovy range; reaching it requires titrating upward from 0.25 mg under prescriber guidance, typically over many months. Jumping straight to a high strength is not how this medicine works, the gradual schedule exists partly to give the body time to adjust and to keep side effects manageable. The NHS's patient information on semaglutide explains the titration process and what to expect at each stage.
For context on what private Wegovy treatment involves from a cost perspective, the Wegovy pricing guide sets out what a transparent private prescription typically covers.
Once you know the pen holds 1.5 ml, the volume question is effectively answered. The more pressing practical matter is keeping that solution at the right temperature. Wegovy pens must be stored in the fridge at 2–8°C until you are ready to use them. There is a limited window during which a pen can be kept at room temperature, but rather than quote a number here, the exact window is stated in your Patient Information Leaflet, and that is the figure to follow. Leaflets reflect the current approved guidance; anything repeated on a webpage can go out of date.
If you have ever wondered whether a pen left out overnight is still safe to use, our guide to Wegovy storage outside the fridge covers the rules clearly. And if you are curious how Wegovy sits alongside other injectable weight-loss options, the distinction between semaglutide-based injections and other GLP-1 medicines is worth reading before making any decisions.
Questions about your specific pen, your dose, or how to inject correctly are best directed to your prescriber or the clinical team who issued your prescription. If you are considering Wegovy and would like a clinician to assess whether it is suitable for you, you can speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not a piece of software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.